The Mission
Neurology services strive for excellence, but a large part of their effectiveness depends on the quality of the tools they rely on. EEG, despite being one of the primary diagnostic tools, is outdated and full of limitations—adding uncertainty even for the best clinicians. In fact, research shows that 70% of routine EEGs provide limited or no useful data, and 30% of epilepsy cases are misdiagnosed. The consequences are high, leading to unnecessary tests and delays in care.
The diagnosis gap: EEG falls short
Today’s EEG technology often falls short. The result? Missed diagnoses, longer waits, and increased patient frustration. As many as 1 in 3 epilepsy cases are incorrectly diagnosed, complicating treatment plans and adding to healthcare burdens. Delays are inevitable: in the UK, it can take over a year to diagnose epilepsy, while conditions like non-epileptic attack disorder can take up to 7 years. Meanwhile, the average waiting time for EEGs in NHS centers is far beyond the recommended two-week target.
Our diagnostic solution is designed to change this. By improving the accuracy and speed of diagnosis, we aim to provide clearer insights from day one, reducing unnecessary tests, and enabling better, quicker care.
The treatment gap: absence of reliable clinical markers
Equally critical is the ability to predict how a patient will respond to treatment. Today, there are no reliable clinical markers to assess treatment progress or predict outcomes. Doctors often depend on patient reports, which can be incomplete or unreliable—leading to a trial-and-error approach to medication.
With our upcoming product, we aim to change that. By providing the tools to monitor treatment progress and predict outcomes, we’re creating a future where patients don’t just receive care—they receive the right care, tailored to their needs, faster.
A better future
The challenges in epilepsy diagnosis and treatment demand innovation. Advances in technology open the door to a new era of advanced EEG’s, empowering neurologists and neurophysiologists with deeper insights, greater confidence, faster diagnosis and more personalised treatment pathways. By complementing clinical expertise with cutting-edge technology, we are enhancing decision-making and improving patient outcomes.
The question is not whether EEG can be improved, but how soon we can make that future a reality.
Fully harnessing the potential of EEG technology
- In up to 70% of cases, especially early on, epileptiform features may not be visible.
- A normal EEG does not rule out epilepsy, creating diagnostic uncertainty.
- The way neurons interact between seizures is different in epilepsy patients vs. non-epileptic individuals. However, these subtle differences are not visible to the human eye when reading EEG data.
- The question is not whether EEG can be improved. It’s how soon we can make that future a reality.
